Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
NCT04577300
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
NT-501
OTHER:
Sham comparator
Sponsor
Stanford University